Hypoxia‐inducible factor 3 alpha is aberrantly detectable in plasma and tumor tissues of NSCLC patients and is a potentially discoverable target gene that might play an effective role in LUAD and LUSC. The gene discussed is HIF3A; the disease is non-small cell lung carcinoma.